INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.73B / 25S · 14 late98 trades$31.71M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,650 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
25
BJ
Bitterman Robert JDirector, Chairman, Pres. & CEO
PHIOPhio Pharmaceuticals Corp.
Open-market purchase
BUY$9,900
10.0K sh
Jun 26, 2026
Page 601 of 1717
← PrevNext →
Jun 29, 2026
traded Jun 26, 2026
+3d
SEC Form 4

Evidence

24
PA
Pillai AnuChief Technology Officer
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
102 sh
Jan 24, 2026Jun 29, 2026
traded Jan 24, 2026
+156dSEC Form 4

Evidence

24
LV
Lowrey Maria VilchezChief Growth Officer
DRCTDirect Digital Holdings, Inc.
Tax withholding
F$13.28
4 sh
Mar 20, 2026Jun 29, 2026
traded Mar 20, 2026
+101dSEC Form 4

Evidence

24
LV
Lowrey Maria VilchezChief Growth Officer
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
19 sh
Aug 22, 2025Jun 29, 2026
traded Aug 22, 2025
+311dSEC Form 4

Evidence

24
LR
Leatherberry Antoinette ReneeDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
90 sh
Jan 24, 2026Jun 29, 2026
traded Jan 24, 2026
+156dSEC Form 4

Evidence

24
LV
Lowrey Maria VilchezChief Growth Officer
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
10 sh
Mar 20, 2026Jun 29, 2026
traded Mar 20, 2026
+101dSEC Form 4

Evidence

24
LM
Locke MistelleDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
34 sh
Jan 16, 2026Jun 29, 2026
traded Jan 16, 2026
+164dSEC Form 4

Evidence

24
PA
Pillai AnuChief Technology Officer
DRCTDirect Digital Holdings, Inc.
Tax withholding
F$16.6
5 sh
Mar 20, 2026Jun 29, 2026
traded Mar 20, 2026
+101dSEC Form 4

Evidence

24
PA
Pillai AnuChief Technology Officer
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
10 sh
Mar 20, 2026Jun 29, 2026
traded Mar 20, 2026
+101dSEC Form 4

Evidence

24
PA
Pillai AnuChief Technology Officer
DRCTDirect Digital Holdings, Inc.
Grant or award
A—
4,375 sh
Mar 24, 2026Jun 29, 2026
traded Mar 24, 2026
+97dSEC Form 4

Evidence

24
LV
Lowrey Maria VilchezChief Growth Officer
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
102 sh
Jan 24, 2026Jun 29, 2026
traded Jan 24, 2026
+156dSEC Form 4

Evidence

24
LV
Lowrey Maria VilchezChief Growth Officer
DRCTDirect Digital Holdings, Inc.
Grant or award
A—
4,375 sh
Mar 24, 2026Jun 29, 2026
traded Mar 24, 2026
+97dSEC Form 4

Evidence

24
HS
Hebbar SudarshanChief Medical Officer
CALCCalciMedica, Inc.
Grant or award
A$100K
124.5K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

24
GE
Giles Bryan ECHIEF FINANCIAL OFFICER
AVOMission Produce, Inc.
Open-market sale
SELL$61K
5,000 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

23
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$387K
7,878 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

22
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Option exercise · 10b5-1 plan
M—
67 sh
Apr 1, 2026Jun 29, 2026
traded Apr 1, 2026
+89dSEC Form 4

Evidence

22
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Tax withholding · 10b5-1 plan
F$1,005
61 sh
Jan 24, 2026Jun 29, 2026
traded Jan 24, 2026
+156dSEC Form 4

Evidence

21
GW
Gassen WilliamDirector
HQYHEALTHEQUITY, INC.
Grant or award
A—
2,877 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

21
HA
Hykes AndrewDirector
SISHOULDER INNOVATIONS, INC.
Grant or award
A—
5,046 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

21
JK
Jackson KristiDirector
NONENONESculptor Diversified Real Estate Income Trust, Inc.
Grant or award
A—
4,713 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

21
JJ
Jenks JohnDirector
NONENONESculptor Diversified Real Estate Income Trust, Inc.
Grant or award
A—
2,142 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

20
LJ
Lieffrig JohnVP and Division Manager
MGRCMCGRATH RENTCORP
Open-market sale · 10b5-1 plan
SELL$250K
2,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

20
BK
Benesh KathrynDirector
CMECME GROUP INC.
Grant or award
A$145K
645 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

20
LM
Locke MistelleDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
90 sh
Jan 24, 2026Jun 29, 2026
traded Jan 24, 2026
+156dSEC Form 4

Evidence

20
AF
Al-Marzooqi FahedDirector
VTVTvTv Therapeutics Inc.
Grant or award
A$210K
6,000 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

19
LR
Leatherberry Antoinette ReneeDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
37 sh
Jun 12, 2026Jun 29, 2026
traded Jun 12, 2026
+17dSEC Form 4

Evidence

19
LM
Locke MistelleDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
37 sh
Jun 12, 2026Jun 29, 2026
traded Jun 12, 2026
+17dSEC Form 4

Evidence

19
LR
Leatherberry Antoinette ReneeDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
159 sh
Jun 9, 2026Jun 29, 2026
traded Jun 9, 2026
+20dSEC Form 4

Evidence

18
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$67K
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$106K
331 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

18
BS
Bobulsky SusanChief Commercial Officer, MRD
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$103K
5,000 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$70K
211 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

18
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Option exercise · 10b5-1 plan
M—
45 sh
Mar 20, 2026Jun 29, 2026
traded Mar 20, 2026
+101dSEC Form 4

Evidence

18
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Option exercise · 10b5-1 plan
M—
67 sh
Apr 1, 2026Jun 29, 2026
traded Apr 1, 2026
+89dSEC Form 4

Evidence

17
SK
Sidow Kevin K.Director
SISHOULDER INNOVATIONS, INC.
Grant or award
A—
5,046 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

17
YJ
Yang JuneDirector
PATHUiPath, Inc.
Grant or award
A—
19.2K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

17
NC
Neal Stephen CDirector
NVDANVIDIA CORP
Grant or award
A—
1,211 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

17
KS
Kaveripatnam SandeshDirector
NAVNNavan, Inc.
Grant or award
A—
9,959 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

17
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$480K
55.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

17
MC
McCowan Debra CharlotteDirector
HQYHEALTHEQUITY, INC.
Grant or award
A—
2,877 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence